{"chunk_type":"transcript_chunk","text":"# Pericardial/Myocardial Structural Signal Comparison Table\n| 질환 | 핵심 단서 | 특징 소견 | 즉시 조치 |\n| --- | --- | --- | --- |\n| Acute pericarditis | positional pleuritic chest pain | friction rub, diffuse ST/PR pattern 가능 | anti-inflammatory 중심 치료 |\n| Constrictive pericarditis | chronic right-sided congestion | pericardial knock, diastolic filling 제한 | 원인교정/수술적 평가 |\n| Myocarditis | viral prodrome 후 심기능 저하 | arrhythmia + new HF pattern | hemodynamic support, trigger evaluation |\n| Cardiac tamponade | hypotension + JVD + muffled heart sounds | pulsus paradoxus, electrical alternans | emergent pericardial drainage |\n\n- tamponade 의심 시 지연 없는 source relief가 생존 결정 요인.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-190","focus_area":"Cardio Structural Signal Table","tags":["usmle-step2","cardiology","pericarditis","tamponade","table"]}
{"chunk_type":"transcript_chunk","text":"# Cardiovascular Pharmacology by Clinical Context (Hero vs Villain)\n## Core principle\n- 같은 약이라도 질환/혈역학 상태에 따라 이득과 위해가 역전된다.\n\n## High-yield context switches\n- CKD/albuminuria HTN에서는 RAAS blockade(ACEi/ARB)가 신장보호 우선.\n- gout에서는 thiazide가 요산 악화 가능, osteoporosis 맥락에서는 이점 가능.\n- ACS/HF에서는 beta-blocker의 timing과 contraindication을 반드시 확인.\n\n## Integration\n- 처방 전 \"현재 stage(급성/만성) + 동반질환 + hemodynamics\" 3축을 확인.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-210","focus_area":"Cardio Pharmacology Context","tags":["usmle-step2","cardiology","pharmacology","hypertension","heart-failure"]}
{"chunk_type":"recap_summary","text":"# Cardio Pharmacology Rapid Recap + Misc Cardio Entry\n- ACS에서 beta-blocker는 안정 혈역학에서 유익하지만 shock/bradycardia에서는 해가 될 수 있다.\n- RV infarct 맥락에서는 preload-dependent physiology를 고려해 nitrate를 피한다.\n- 급성 HF 악화기와 만성 안정기 약물 전략은 다르다.\n- HFrEF에서는 ARNI/ACEi/ARB + BB + MRA + SGLT2i 기반이 생존이득 축.\n\n## Transition\n- 다음은 syncopal syndromes, tamponade physiology, vascular anomaly 같은 \"misc but high-yield\" 통합 개념.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-230","focus_area":"Cardio Pharm Recap and Misc Entry","tags":["usmle-step2","cardiology","recap","pharmacology"]}
{"chunk_type":"transcript_chunk","text":"# Cardio Misc Integration: Syncope, Tamponade, Device Thrombosis, HHT\n## Syncope split\n- vasovagal syncope: trigger/prodrome + reflex bradycardia/vasodilation.\n- exertional syncope in athletes: structural/electrical lethal causes(AAOCA/HCM 등) 우선 배제.\n\n## Tamponade physiology\n- pulsus paradoxus와 ventricular interdependence를 연결해 해석.\n\n## Device-related risk\n- DAPT 중단 후 stent thrombosis, 기계판막 항응고 불균형은 고위험 사건으로 직결.\n\n## HHT bridge\n- recurrent epistaxis + AVM 맥락에서 paradoxical embolic infection/stroke risk를 평가.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-240","focus_area":"Cardio Misc Syncope Tamponade HHT","tags":["usmle-step2","cardiology","syncope","tamponade","hht"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Cardiology Entry: Cyanotic Infant First-pass Algorithm\n## First decision: lung vs heart cyanosis\n- hyperoxia test에서 산소 반응이 제한되면 intracardiac/right-to-left shunt 가능성 증가.\n\n## Duct-dependent physiology\n- 일부 critical congenital heart disease는 PDA patency 유지가 생존 핵심.\n- PGE1이 초기 bridge therapy가 될 수 있다.\n\n## Target diseases in this block\n- VSD, tricuspid atresia, PPHN, HLHS를 시나리오 기반으로 구분.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-260","focus_area":"Pediatric Cardio Cyanosis Entry","tags":["usmle-step2","pediatrics","cardiology","cyanosis","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Cyanotic Lesion Comparison Table\n| 질환 | 핵심 병태생리 | 대표 단서 | 초기 관리 포인트 |\n| --- | --- | --- | --- |\n| VSD (large) | left-to-right shunt로 pulmonary overcirculation | CHF/poor feeding/failure to thrive | diuretic/nutrition/support, 필요 시 수술 |\n| Tricuspid atresia | RV inflow obstruction + mixing dependence | cyanosis + characteristic ECG axis clue | PDA/atrial-level mixing support |\n| PPHN | pulmonary vascular resistance가 태아형으로 유지 | differential oxygenation pattern | oxygenation + pulmonary vasodilation 전략 |\n| HLHS | left-sided systemic output failure | duct-dependent systemic perfusion | PGE1 + staged palliation pathway |","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-280","focus_area":"Pediatric Cyanotic Lesion Table","tags":["usmle-step2","pediatrics","cardiology","congenital-heart","table"]}
{"chunk_type":"transcript_chunk","text":"# VSD and Tricuspid Atresia High-yield Distinction\n## VSD paradox\n- small defect는 loud murmur but hemodynamic impact는 상대적으로 적을 수 있음.\n- large defect는 murmur가 덜 극적이어도 volume overload/HF 위험이 큼.\n\n## Tricuspid atresia clue\n- cyanotic infant에서 RV hypoplasia physiology와 axis pattern을 연결.\n- intracardiac shunt 경로가 생존에 필수라는 점을 기억.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-300","focus_area":"VSD and Tricuspid Atresia","tags":["usmle-step2","pediatrics","vsd","tricuspid-atresia"]}
{"chunk_type":"transcript_chunk","text":"# Preoperative Cardiac Risk: RCRI + Functional Capacity Table\n| 질문 | 평가 항목 | 해석 |\n| --- | --- | --- |\n| 수술 자체 위험 | 고위험 수술 여부 | baseline procedural risk 설정 |\n| 환자 위험 | RCRI 요소(심질환/CHF/CVA/insulin DM/Cr 등) | periop MACE 추정 |\n| 기능 상태 | METs (≥4 여부) | 추가 검사 필요성 결정 |\n\n## Practical algorithm\n- emergency면 즉시 수술 경로.\n- active cardiac condition이면 먼저 심장안정화.\n- 나머지는 RCRI + METs로 testing 필요 여부를 계층화.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-320","focus_area":"Preop Cardiac Risk Framework","tags":["usmle-step2","cardiology","perioperative","rcri","table"]}
{"chunk_type":"transcript_chunk","text":"# Perioperative Special Cases: Valve Disease, Arrhythmia, Anticoagulation\n## Valve disease\n- symptomatic severe valvular lesion은 비심장 수술 전 교정 우선 고려.\n\n## Arrhythmia\n- rate/rhythm 안정화와 thromboembolic risk를 동시에 관리.\n\n## Anticoagulation periop\n- thrombotic risk가 높은 집단(예: mechanical valve 등)에서는 bridging 전략 검토.\n- low-risk는 단순 중단/재개 전략이 가능.\n\n## Testing discipline\n- 저위험 환자에서 무분별한 pre-op testing을 피하고, indication-based로 시행.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-340","focus_area":"Perioperative Special Cases","tags":["usmle-step2","cardiology","perioperative","arrhythmia","anticoagulation"]}
{"chunk_type":"transcript_chunk","text":"# Postoperative and Vascular Trauma Triage Table\n| 상황 | 핵심 단서 | 즉시 대응 |\n| --- | --- | --- |\n| Sternal dehiscence | click/instability at sternum | surgical fixation 평가 |\n| Post-pericardiotomy syndrome | 수주 후 pleuritic pain/fever/rub | anti-inflammatory management |\n| Cardiac tamponade | Beck triad/hemodynamic collapse | urgent drainage |\n| Vascular trauma hard signs | pulsatile bleeding/expanding hematoma/ischemia | 즉시 OR (영상 지연 금지) |\n| Vascular trauma soft signs | 애매한 neurovascular change | CTA/Doppler 후 계획 치료 |\n\n- blunt cardiac injury는 ECG rhythm monitoring이 핵심.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-360","focus_area":"Postop and Vascular Trauma Table","tags":["usmle-step2","trauma","cardiology","vascular-trauma","table"]}
{"chunk_type":"transcript_chunk","text":"# Perioperative and Trauma Rapid Recap\n1. pre-op 평가는 \"응급 여부 -> active cardiac issue -> RCRI/METs\" 순서.\n2. high-risk anticoagulated patient는 bridging 필요성을 별도 평가.\n3. postoperative tamponade/dehiscence는 시간 지연이 치명적.\n4. vascular trauma에서 hard sign은 imaging보다 OR 우선.\n5. blunt chest trauma는 arrhythmia surveillance를 놓치지 않는다.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-380","focus_area":"Periop Trauma Recap","tags":["usmle-step2","cardiology","recap","perioperative","trauma"]}
{"chunk_type":"transcript_chunk","text":"# Gynecology Physiology Lifecycle Framework\n## Lifecycle tree overview\n- puberty -> reproductive cycle issues -> menopause/postmenopausal red flag 순서로 접근.\n\n## Core rule\n- 연령대 + symptom timing을 매칭하면 진단 분기가 빨라진다.\n\n## High-yield anchors\n- puberty sequence, cyclic mood/pain disorders, menopause treatment constraints, postmenopausal bleeding workup.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-1","focus_area":"Gyne Lifecycle Framework","tags":["usmle-step2","gynecology","physiology","lifecycle"]}
{"chunk_type":"transcript_chunk","text":"# Reproductive-age Gyne Differential Table (Timing + Exam Pattern)\n| 문제 | 타이밍/병태생리 | 핵심 단서 | 우선 관리 |\n| --- | --- | --- | --- |\n| PMS/PMDD | luteal phase cyclic symptom | symptom-free interval 존재 | SSRI/생활개입, severe면 escalated care |\n| Primary dysmenorrhea | prostaglandin-mediated pain | normal pelvic exam | NSAID 우선 |\n| Endometriosis | ectopic endometrial tissue | dysmenorrhea + dyspareunia + dyschezia | hormonal/surgical context care |\n| Adenomyosis | myometrial invasion | boggy globally enlarged tender uterus | symptom-directed management |\n| Fibroid | leiomyoma mass effect | irregular/lumpy uterus, heavy bleeding | imaging + medical/procedural care |","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-21","focus_area":"Reproductive-age Gyne Differential","tags":["usmle-step2","gynecology","dysmenorrhea","pms-pmdd","table"]}
{"chunk_type":"transcript_chunk","text":"# Menopause and Postmenopausal Bleeding Management\n## Menopause care\n- diagnosis는 12개월 무월경 + 호르몬 축 변화 맥락.\n- GSM는 nonhormonal부터 시작하고 필요 시 topical estrogen으로 단계 상승.\n- vasomotor symptom HRT는 금기 여부와 uterus 존재 여부에 따라 regimen 결정.\n\n## Postmenopausal bleeding red flag\n- endometrial malignancy 배제를 최우선으로 두고 TVUS/endometrial sampling 알고리즘을 따른다.\n- endometrial thickness와 clinical risk를 통합해 biopsy 필요성을 결정.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-41","focus_area":"Menopause and PMB","tags":["usmle-step2","gynecology","menopause","postmenopausal-bleeding"]}
{"chunk_type":"recap_summary","text":"# Gyn Lifecycle Rapid Recap + Next Scaffold Entry\n1. puberty sequence를 혼동하지 말고 growth spurt timing 함정을 피한다.\n2. cyclic symptoms는 timing diary가 진단 정확도를 높인다.\n3. dysmenorrhea는 primary vs secondary(구조병변)로 분기해 접근한다.\n4. menopause HRT는 contraindication과 uterus 유무를 반드시 확인.\n5. postmenopausal bleeding은 cancer until proven otherwise 원칙.\n\n## Transition\n- 다음 블록은 reproductive health의 더 넓은 임상 시나리오를 논리 트리로 확장.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-53","focus_area":"Gyne Rapid Recap","tags":["usmle-step2","gynecology","recap","next-step"]}
